Periodontal associations in cardiovascular diseases: The latest evidence and understanding

Journal of Oral Biology and Craniofacial Research

Volumn 5, Issue 3, 2015, Pages 203-206

  Nguyen, C M ^a   Kim, J W M ^b   Quan, V H ^c   Nguyen, B H ^d   Tran, S D ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Private Office   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cardiovascular diseases; Inflammatory cytokines; Oral pathogens; Periodontal disease; Systemic inflammation

Indexed keywords

EID: 84969142130     PISSN: 22124268     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jobcr.2015.06.008     Document Type: Review

References (17)

1. Mitchell M.E., Sidawy A.N. The pathophysiology of atherosclerosis. Semin Vasc Surg 1998, 11(3):134-141.
2. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442.
3. Tonetti M.S., Van Dyke T.E. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013, 84(4 suppl):S24-S29.
4. Lindhe J., Haffajee A.D., Socransky S.S. Progression of periodontal disease in adult subjects in the absence of periodontal therapy. J Clin Periodontol 1983, 10(4):433-442.
5. Van Dyke T.E., van Winkelhoff A.J. Infection and inflammatory mechanisms. J Periodontol 2013, 84(4 suppl):S1-S7.
6. Schenkein H.A., Loos B.G. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol 2013, 84(4 suppl):S51-S69.
7. Lockhart P.B., Bolger A.F., Papapanou P.N., et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation 2012, 125(20):2520-2544.
8. Prochnau D., Lehmann M., Straube E., Figulla H.R., Rödel J. Human cytomegalovirus induces MMP-1 and MMP-3 expression in aortic smooth muscle cells. Acta Microbiol Immunol Hung 2011, 58(4):303-317.
9. Bartruff J.B., Yukna R.A., Layman D.L. Outer membrane vesicles from Porphyromonas gingivalis affect the growth and function of cultured human gingival fibroblasts and umbilical vein endothelial cells. J Periodontol 2005, 76(6):972-979.
10. Fitzpatrick R.E., Wijeyewickrema L.C., Pike R.N. The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol 2009, 4(4):471-487.
11. Oscarsson J., Karched M., Thay B., Chen C., Asikainen S. Proinflammatory effect in whole blood by free soluble bacterial components released from planktonic and biofilm cells. BMC Microbiol 2008, 8:206.
12. D'Aiuto F., Orlandi M., Gunsolley J.C. Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Periodontol 2013, 84(4 suppl):S85-S105.
13. Blake G.J., Ridker P.M. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002, 252(4):283-294.
14. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation: aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336(14):973-979.
15. Freitas C.O., Gomes-Filho I.S., Naves R.C., et al. Influence of periodontal therapy on C-reactive protein level: a systematic review and meta-analysis. J Appl Oral Sci 2012, 20(1):1-8.
16. Higashi Y., Goto C., Hidaka T., et al. Oral infection-inflammatory pathway: periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease. Atherosclerosis 2009, 206(2):604-610.
17. Armitage G.C. The complete periodontal examination. Periodontol 2004, 2000(34):22-33.